The Saudi Arabia and Egypt healthcare 3D printing market size was valued at USD 9.5 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 15.6% from 2023 to 2030. The rising prevalence of chronic diseases and increased government investments and R&D in 3D printing technology are the key factors driving the market. During the COVID-19 pandemic, Saudi Arabia and Egypt faced supply and manufacturing challenges like other regions and countries. Despite supply chain and logistics disruptions and shortages of products and medical supplies, the pandemic has positively impacted the 3D printing technology market as 3D printing can be highly useful in creating point-of-care tools effectively and with high reproducibility. Several 3D printing companies, such as Formlabs, Prusa, and Stratasys, are publishing their designs online and offering design standards for producing face shields. As a result, the market for medical 3D printers is significantly expanding.
3D printing is regarded as the next industrial revolution in manufacturing, with a high potential to provide cost-effective methods to achieve complex and customized medical parts and components, such as tissues, organs, orthopedic and cranial implants, and dental prosthetics. Moreover, technological advancements and growing consumer awareness regarding enhanced applications of additive manufacturing techniques are anticipated to increase the scope of bioengineered healthcare products, thus fueling the growth of 3D printing manufacturing. For instance, medical technology firms such as Stryker have introduced precise medical parts of titanium-based anterior and posterior cervical cages developed by 3D printing.
According to the American Society of Nephrology and ERA-EDTA, in 2018, nearly 850 million individuals were suffering from some form of kidney disease and nearly 10.5 million individuals required transplants or dialysis globally. Thus, the high prevalence of kidney diseases along with the shortage of organ donors is expected to boost the need for advanced regenerative medicines and tissue engineering technologies, such as 3D printing.
The adoption of 3D-printed medicines is likely to improve owing to various initiatives undertaken by the government to enhance research in personalized medicines. For instance, in April 2021, the Smart-Health Initiative was launched by the Saudi Arabian government to improve the adoption of personalized medicine in the country.
In March 2022, 3D Systems, an additive manufacturing solutions company dealing in the Industrial and Healthcare markets, signed an agreement with the Saudi Arabian Industrial Investments Company (Dussur) to increase the use of additive manufacturing in the Kingdom of Saudi Arabia and the larger MENA area. This deal was made to increase the country’s domestic additive manufacturing capabilities in industrial and healthcare applications as a part of its Vision 2030 program. Such deals and initiatives are likely to drive the market for healthcare 3D printing in the country.
The implants segment led the market in 2022 with a revenue share of more than 60.0% as 3D implants are in high demand and have been quietly revolutionized by additive manufacturing. This expansion in the implant industry is happening in numerous implant areas such as hip, spinal, knee, and other types of implants. Porous metal implants are a popular choice as they have similar mechanical properties to human bone, with enough stability and strength.
The implants segment is also estimated to register the highest growth rate over the forecast years due to the high accuracy and cost-effectiveness of 3D printing technology in the implant industry. For instance, Health Canada has approved the first Canadian-made 3D-printed medical implant, which is a customizable mandibular plate that is used in facial reconstruction surgery for patients with oral cancer.
3D printing techniques for medical device (orthopedic and cranial implants, surgical instruments, dental restorations) manufacturing such as stereolithography (SLA), selective laser sintering (SLS), fused deposition modeling (FDM) for plastic parts, and direct metal laser sintering (DMLS), and selective laser melting (SLM) for metals are gaining high popularity and is expected to significantly penetrate Saudi Arabian and Egypt healthcare market.
The photopolymerization segment accounted for the largest revenue share of over 35.0% in 2022. Photopolymerization is a method of solidifying photosensitive resin. This technique is used to produce micrometer-sized 3D structures. Photopolymerization is further segmented into Digital Light Processing (DLP), Stereolithography, and Two-Photon Polymerization (TPP). Photopolymers are very versatile and can be used to create objects that adhere to a wide range of benefits, such as flexibility, transparency, and strength. Stereolithography is one of the first employed mechanisms for 3D printing wherein three-dimensional objects are made by curing a photo-hardening polymer with UV light.
The droplet deposition segment is expected to register a significant growth rate of 16.1% over the forecast period. Droplet deposition is segmented into Inkjet Printing (IJP), FDM, and Multiphase Jet Solidification (MJS). It uses a liquid-phase rapid prototyping technology to create 3D parts. It is a quick, adaptable, and affordable technique that enables the construction of both simple and complex 3D objects.
The polymers segment dominated the market and accounted for a revenue share of more than 50.0% in 2022. Polymer 3D printing is being highly used to manufacture 3D printed replicas of human organs, in preoperative planning, and for surgical guidance. Apart from this, polymer 3D printing is also being utilized to create personalized medical items on demand, including affordable prosthetics and dental tools such as bridges and aligners. On the basis of material, the market has been divided into metals, polymers, biological cells, and ceramics.
The biological cells segment is expected to register the highest growth rate of 17.4% during the forecast period as the technology has the potential to completely transform the way diseases are treated by replacing animal testing and reducing the organ transplant waiting list. The geometry of a 3D bioprinted tissue is similar to that of naturally occurring tissue. Besides 3D bioprinting, no other technology enables the simulation of the level of geometric complexity in tissue engineering. As per Frontiers pen Access Journal, Additive manufacturing is currently among the most advanced techniques utilized in this area of tissue engineering by building complex tissue in a layer-by-layer fashion, thereby producing precise geometries.
The medical and surgical centers segment dominated the market and accounted for a revenue share of more than 70.0% in 2022. The high burden of diseases in the Kingdom of Saudi Arabia (KSA) and Egypt requiring surgeries is one of the key factors driving the segment. For instance, in July 2019, the Frontiers published research stating that the severity and prevalence of dental caries in Saudi Arabia are high. On the basis of end-user, the market has been divided into medical and surgical centers, pharma and biotech companies, and academic institutions.
Pharma and biotech companies are expected to register a lucrative growth rate of 15.3% during the forecast period due to the high demand for 3D printing technology in the pharma industry for developing and manufacturing products. In March 2021, Leap, a publishing news company, reported that Saudi Arabia is making significant investments across its scientific and medical universities in bioprinting that includes optimization of a 3D bioprinting process using ultrashort peptide bioinks.
The market players are developing high-tech 3D products to expand their product portfolio. For instance, Stratasys Ltd. improved its J750 Digital Anatomy 3D printer capabilities by adding advanced bone capabilities to support clinical research. This enhancement was made to assist the researchers in developing models that behave like bones.
However, the pandemic situation has slowed down sales to a significant extent. The COVID-19 pandemic has also brought certain opportunities to the market players. For instance, market players are starting to mobilize their additive manufacturing network and leverage application expertise with their corporate-wide resources to help get a variety of printed parts where they are needed the most for providing better patient care. Some prominent players in Saudi Arabia and Egypt healthcare 3D printing market include:
3D Systems, Inc.
Organovo Holdings Inc.
Envisiontec US LLC
Market size value in 2023
USD 12.1 million
Revenue forecast in 2030
USD 30.4 million
CAGR of 15.6% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD million and CAGR from 2023 to 2030
Revenue forecast, competitive landscape, growth factors, and trends
Application, technology, material, end-use
Saudi Arabia; Egypt
Key companies profiled
Covestro AG; Stratasys Ltd.; 3D Systems, Inc.; General Electric; Organovo Holdings Inc.; 3DVinci Creations; AddUp; SLM Solutions; Envisiontec US LLC; Cellink
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, and segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the Saudi Arabia and Egypt healthcare 3D printing market report on the basis of application, technology, material, and end-use:
Application Outlook (Revenue, USD Million, 2018 - 2030)
Orthopedic Surgical Guides
Cranio-maxillofacial Surgical Guides
Dental Surgical Guides
Technology Outlook (Revenue, USD Million, 2018 - 2030)
Electron Beam Melting
Laser Beam Melting
Digital Light Processing (DLP)
Two-Photon Polymerization (TPP)
Inkjet Printing (IJP)
Fused Deposition Modeling (FDM)
Multiphase Jet Solidification (MJS)
Material Outlook (Revenue, USD Million, 2018 - 2030)
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Medical & Surgical Centers
Pharma & Biotech Companies
b. The Saudi Arabia and Egypt healthcare 3D printing market size was estimated at USD 9.5 million in 2022 and is expected to reach USD 12.1 million in 2023.
b. The Saudi Arabia and Egypt healthcare 3D printing market is expected to grow at a compound annual growth rate of 15.6% from 2023 to 2030 to reach USD 30.4 million by 2030.
b. The implants segment dominated the Saudi Arabia and Egypt healthcare 3D printing market with a share of 64.9% in 2022. This is attributable to fact that 3D printed implants offer several benefits such as cost-effectiveness and customization.
b. Some key players operating in Saudi Arabia and Egypt healthcare 3D printing market include Covestro AG, Stratasys Ltd., 3D Systems, Inc., General Electric, Organovo Holdings Inc., 3DVinci Creations, AddUp, SLM Solutions, Envisiontec US LLC, and Cellink.
b. Key factors that are driving the market growth include an increase in the number of surgeries & implantation and growing demand for 3D printing technology.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."